MX2018002462A - Una composicion farmaceutica para reducir la grasa localizada y sus usos. - Google Patents
Una composicion farmaceutica para reducir la grasa localizada y sus usos.Info
- Publication number
- MX2018002462A MX2018002462A MX2018002462A MX2018002462A MX2018002462A MX 2018002462 A MX2018002462 A MX 2018002462A MX 2018002462 A MX2018002462 A MX 2018002462A MX 2018002462 A MX2018002462 A MX 2018002462A MX 2018002462 A MX2018002462 A MX 2018002462A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- fat
- composition used
- reducing localised
- reducing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000000693 micelle Substances 0.000 abstract 2
- 229940109262 curcumin Drugs 0.000 abstract 1
- 235000012754 curcumin Nutrition 0.000 abstract 1
- 239000004148 curcumin Substances 0.000 abstract 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención proporciona una composición farmacéutica para reducir la grasa localizada, que comprende micelas que contienen medicamento elaboradas de tensioactivos, y curcumina encapsuladas en las micelas que contienen medicamento. Esta composición farmacéutica para reducir la grasa localizada puede reducir la grasa en el sitio de administración y tiene las ventajas de alta estabilidad, alta biodisponibilidad para el tejido graso, pocos efectos secundarios y liberación sostenida.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2015/088340 WO2016029870A1 (zh) | 2014-08-28 | 2015-08-28 | 用于减少局部脂肪与减少体重的组合物及其医药品与应用 |
US201562257846P | 2015-11-20 | 2015-11-20 | |
US201662299702P | 2016-02-25 | 2016-02-25 | |
PCT/IB2016/055102 WO2017037594A2 (zh) | 2015-08-28 | 2016-08-26 | 用于减少局部脂肪的医药组成物及其用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018002462A true MX2018002462A (es) | 2018-06-19 |
Family
ID=58186932
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018002462A MX2018002462A (es) | 2015-08-28 | 2016-08-26 | Una composicion farmaceutica para reducir la grasa localizada y sus usos. |
MX2018002461A MX2018002461A (es) | 2015-08-28 | 2016-08-26 | Una composicion farmaceutica para reducir la grasa localizada y sus usos. |
MX2021010359A MX2021010359A (es) | 2015-08-28 | 2018-02-27 | Una composicion farmaceutica para reducir la grasa localizada y sus usos. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018002461A MX2018002461A (es) | 2015-08-28 | 2016-08-26 | Una composicion farmaceutica para reducir la grasa localizada y sus usos. |
MX2021010359A MX2021010359A (es) | 2015-08-28 | 2018-02-27 | Una composicion farmaceutica para reducir la grasa localizada y sus usos. |
Country Status (15)
Country | Link |
---|---|
US (4) | US10610496B2 (es) |
EP (2) | EP3381473A4 (es) |
JP (5) | JP7063803B2 (es) |
KR (4) | KR102240221B1 (es) |
CN (3) | CN108697668B (es) |
AU (5) | AU2016314545C1 (es) |
BR (2) | BR112018003892A2 (es) |
CA (2) | CA2995158C (es) |
CO (1) | CO2018003424A2 (es) |
IL (1) | IL257784B2 (es) |
MX (3) | MX2018002462A (es) |
RU (1) | RU2753507C2 (es) |
SG (1) | SG11201801111RA (es) |
TW (3) | TWI604859B (es) |
WO (2) | WO2017037593A2 (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10537548B2 (en) | 2014-08-28 | 2020-01-21 | Caliway Biopharmaceuticals Co., Ltd. | Composition and medical product for reducing body weight and body fat, and use of said product |
MX2018002462A (es) * | 2015-08-28 | 2018-06-19 | Caliway Biopharmaceuticals Co Ltd | Una composicion farmaceutica para reducir la grasa localizada y sus usos. |
US11318110B2 (en) | 2015-08-28 | 2022-05-03 | Caliway Biopharmaceuticals Co., Ltd. | Pharmaceutical composition for reducing local fat and uses thereof |
EP3505168A1 (en) | 2016-08-26 | 2019-07-03 | Caliway Biopharmaceuticals Co., Ltd. | Subcutaneous injection for reducing body weight and application thereof |
EP3541815A4 (en) | 2016-11-18 | 2020-07-15 | Pacira Pharmaceuticals, Inc. | ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME |
KR20190134671A (ko) * | 2017-03-28 | 2019-12-04 | 칼리웨이 바이오파마슈티칼스 코., 엘티디. | 체중을 감소시키고 체지방을 감소시키기 위한 조성물 및 그의 제약 생성물 및 적용 |
WO2020194344A1 (en) | 2019-03-24 | 2020-10-01 | Patel Naishadhkumar Ramubhai | Formulation to enhance the bioavailibity and stability of curcuminoids and/or its derivatives thereof |
CN110934827B (zh) * | 2019-11-08 | 2021-03-19 | 江西中医药大学 | 一种口服葛根素混合胶束制剂、制备方法及应用 |
CN113730650B (zh) * | 2021-10-13 | 2022-11-01 | 哈尔滨泽润医疗机构管理有限公司 | 一种碳水溶酶组合物及其制备方法和应用 |
WO2023192259A1 (en) * | 2022-03-28 | 2023-10-05 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Synergy for increasing insulin sensitivity |
US20230372378A1 (en) * | 2022-05-16 | 2023-11-23 | Caliway Biopharmaceuticals Co., Ltd. | Compositions and methods for alleviating conditions caused by abnormal subcutaneous deposit of adipose tissue or fat |
Family Cites Families (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048736A (en) * | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
ES2433678T3 (es) * | 1999-03-03 | 2013-12-12 | Eli Lilly & Company | Formulaciones farmacéuticas de equinocandina que contienen tensioactivos formadores de micelas |
DE60031921T2 (de) * | 1999-08-16 | 2007-09-20 | Dsm Ip Assets B.V. | Verfahren zu Herstellung von Epigallocatechin Gallate |
US6475530B1 (en) | 2000-05-31 | 2002-11-05 | Eric H. Kuhrts | Methods and compositions for producing weight loss |
US6383482B1 (en) * | 2000-08-24 | 2002-05-07 | Vitacost.Com, Inc. | Weight loss composition containing green tea, hydroxycitric acid, 5-hydroxytryptophan, glucomannan, picolinate and lactobacillus |
US20040071799A1 (en) | 2001-02-12 | 2004-04-15 | Xiurong Xu | Herbal compositions and methods for effecting weight loss in humans |
JP4179494B2 (ja) | 2001-10-23 | 2008-11-12 | 株式会社カネカ | ペルオキシソーム増殖剤応答性受容体リガンド剤 |
US20040146539A1 (en) | 2003-01-24 | 2004-07-29 | Gupta Shyam K. | Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits |
US20060121158A1 (en) | 2003-06-04 | 2006-06-08 | Mario Ferruzzi | Weight management beverage |
CN100539988C (zh) * | 2003-06-27 | 2009-09-16 | 株式会社太平洋 | 含有生理活性成分的自聚集聚合物纳米颗粒和含有该纳米颗粒的外用搽剂 |
CA2548671C (en) | 2003-12-29 | 2015-02-24 | President And Fellows Of Harvard College | Compositions for treating or preventing obesity and insulin resistance disorders |
US20050232974A1 (en) * | 2004-04-19 | 2005-10-20 | Gore Makarand P | System and a method for pharmaceutical dosage preparation using jettable microemulsions |
US20050267221A1 (en) * | 2004-05-14 | 2005-12-01 | Research Development Foundation | Use of curcumin and analogues thereof as inhibitors of ACC2 |
CN100486567C (zh) * | 2004-08-12 | 2009-05-13 | 山东绿叶天然药物研究开发有限公司 | 姜黄素乳剂及其制备方法 |
WO2006074278A2 (en) | 2005-01-05 | 2006-07-13 | Mitsunori Ono | Compositions for treating diabetes or obesity |
WO2006082068A1 (de) | 2005-02-04 | 2006-08-10 | Peter Heger | Verwendung einer hydroxystilben-haltigen wirkstoffkombination zur prävention und/oder behandlung von krankheiten |
ITFI20050031A1 (it) | 2005-02-21 | 2006-08-22 | Stefan Coccoloni | Una composizione farmaceutica atta a prevenire l'invecchiamento e l'insorgere di malattie vascolari,neoplastiche,cutanee e dell'apparato pilifero |
AU2006270165B2 (en) | 2005-07-14 | 2010-03-11 | Neothetics, Inc. | Sustained release enhanced lipolytic formulation for regional adipose tissue treatment |
JP2007063137A (ja) | 2005-08-29 | 2007-03-15 | Daicho Kikaku:Kk | 抗肥満薬 |
WO2007041276A2 (en) | 2005-09-29 | 2007-04-12 | New Chapter, Inc. | Methods for modulating apoptosis, cellgrowth, and protein expression with herbal compositions |
JP2007131603A (ja) | 2005-11-14 | 2007-05-31 | Kaneka Corp | L−カルニチン合成系酵素遺伝子の転写促進用組成物 |
CN100367951C (zh) * | 2005-12-16 | 2008-02-13 | 石药集团恩必普药业有限公司 | 丁苯酞静脉乳剂及其应用 |
WO2007103435A2 (en) * | 2006-03-06 | 2007-09-13 | The Regents Of The University Of California | Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders |
WO2007112996A2 (en) | 2006-03-31 | 2007-10-11 | Dsm Ip Assets B.V. | Novel use of compounds and combinations of compunds for improving the physical appearance |
US7977319B1 (en) | 2006-04-03 | 2011-07-12 | Scott David Levine | Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins |
WO2007113008A2 (en) * | 2006-04-04 | 2007-10-11 | Dsm Ip Assets B.V. | Opaque container comprising food or pharmaceutical products or herbal(s) |
CN101095665A (zh) | 2006-06-27 | 2008-01-02 | 中国科学院上海生命科学研究院 | Sirt1在预防、控制或治疗肥胖中的用途 |
US7923026B2 (en) * | 2006-10-20 | 2011-04-12 | Solvay Pharmaceuticals B.V. | Embedded micellar nanoparticles |
JP2008133272A (ja) * | 2006-10-31 | 2008-06-12 | Ito En Ltd | Cpt活性亢進剤及び飲食物 |
KR101069502B1 (ko) * | 2006-10-31 | 2011-09-30 | (주)아모레퍼시픽 | 비만 및 당뇨병 개선용 경구용 조성물 |
CN101310718A (zh) * | 2007-05-23 | 2008-11-26 | 中国科学院上海生命科学研究院 | 减肥降血脂的含儿茶素的组合物及其用途 |
CN102357226B (zh) | 2007-08-07 | 2013-07-10 | 北京北大维信生物科技有限公司 | 中草药姜黄的醇提取物在制备具有脂肪酶活性抑制作用的药物中的应用 |
WO2009066303A2 (en) | 2007-11-22 | 2009-05-28 | Ganga Raju Gokaraju | New synergistic phytochemical composition for the treatment of obesity |
EP2249806A2 (en) * | 2008-01-08 | 2010-11-17 | Sirtris Pharmaceuticals, Inc. | Resveratrol formulations |
JP5564490B2 (ja) | 2008-04-18 | 2014-07-30 | リアタ ファーマシューティカルズ インコーポレイテッド | 抗炎症性ファルマコアを含む化合物および使用法 |
EP2429481A4 (en) * | 2008-06-25 | 2014-08-13 | Elc Man Llc | METHOD AND COMPOSITIONS FOR IMPROVING THE APPEARANCE OF SKIN AND BODY |
WO2010048114A1 (en) | 2008-10-22 | 2010-04-29 | Metaproteomics, Llc | Novel mitochondrial uncoupling methods and compositions for enhancing adipocyte thermogenesis |
US8496974B2 (en) * | 2008-11-25 | 2013-07-30 | Oy Granula Ab Ltd | Method for preparing a composition comprising a compound mixture and a carrier agent |
CN102264348A (zh) * | 2008-11-26 | 2011-11-30 | 脂蛋白技术有限公司 | 生物活性提高的白藜芦醇制剂 |
MA33220B1 (fr) * | 2009-03-20 | 2012-04-02 | Bioxtract S A | Composition pharmaceutique a proprietes anti-inflammatoires |
CN101874763A (zh) * | 2009-04-29 | 2010-11-03 | 上海家化联合股份有限公司 | 一种白藜芦醇柔性脂质体及其制备方法 |
KR20100124519A (ko) * | 2009-05-19 | 2010-11-29 | (주)아모레퍼시픽 | 녹차 추출물을 함유하는 조성물 |
CN101632655B (zh) | 2009-08-04 | 2011-12-07 | 南京大渊美容保健有限公司 | 延缓衰老的白藜芦醇和生物类黄酮营养组合物 |
JP5594819B2 (ja) | 2009-12-22 | 2014-09-24 | キリンホールディングス株式会社 | 脂質代謝改善用組成物 |
CN104771364B (zh) * | 2010-03-10 | 2018-05-25 | 艾伯维巴哈马有限公司 | 固体组合物 |
US8835509B2 (en) | 2010-05-31 | 2014-09-16 | Arbro Pharmaceuticals Ltd. | Self emulsifying drug delivery system for a curcuminoid based composition |
WO2012003515A2 (en) * | 2010-07-02 | 2012-01-05 | Eric Hauser Kuhrts | Stable fatty acid-containing formulations |
JP6043283B2 (ja) | 2010-07-02 | 2016-12-14 | ヘリックス バイオメディックス, インコーポレイテッドHelix Biomedix, Inc. | セルライト等の皮膚状態を治療するためのn−アシルアミノ酸誘導体 |
KR101640258B1 (ko) * | 2010-07-05 | 2016-07-15 | 주식회사 엘지생활건강 | 적포도 추출물, 녹차 추출물, 대두 추출물 및 l-카르니틴을 유효성분으로 함유하는 항비만 조성물 |
US20130143869A1 (en) | 2010-07-16 | 2013-06-06 | Merz Pharma Gmbh & Co. Kgaa | Use of a cationic amphiphilic drug for the preparation of a formulation for the reduction of subcutaneous adipose tissue |
US20120088829A1 (en) * | 2010-09-29 | 2012-04-12 | MyCell Holdings Limited | Formulations of Ubiquinol and Resveratrol Esters |
CN102106816A (zh) * | 2010-12-16 | 2011-06-29 | 天津迈迪瑞康生物医药科技有限公司 | 一种白藜芦醇纳米制剂及其制备方法 |
US8815310B2 (en) | 2011-01-10 | 2014-08-26 | Morteza Naghavi | Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health |
CN102512404B (zh) | 2011-11-18 | 2014-05-07 | 上海交通大学 | 一种姜黄素类化合物肺靶向制剂及其制备方法与应用 |
EP2799081A4 (en) | 2011-12-27 | 2015-06-24 | Tokiwa Phytochemical Co Ltd | SIRTUIN ACTIVATOR |
US20140348926A1 (en) * | 2012-01-19 | 2014-11-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Formulation and method for increasing oral bioavailability of drugs |
US8496979B1 (en) | 2012-02-02 | 2013-07-30 | Reliv International, Inc. | Caffeine-free dietary supplements for increasing energy and methods of administering the same |
CN104125848A (zh) | 2012-02-29 | 2014-10-29 | 雅芳产品公司 | Cpt-1调节剂的用途及其组合物 |
US8652518B2 (en) | 2012-04-15 | 2014-02-18 | Jahahreeh Finley | Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation |
WO2014025672A1 (en) | 2012-08-04 | 2014-02-13 | Eric Hauser Kuhrts | Water-soluble lipophilic natural compound formulations |
WO2014028607A1 (en) * | 2012-08-14 | 2014-02-20 | Abbott Laboratories | Low glycemic index nutritional compositions for preserving muscle mass and improving body composition in diabetics |
US9211298B2 (en) | 2012-11-16 | 2015-12-15 | Song Gao | Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses |
DE202012012130U1 (de) * | 2012-12-19 | 2014-03-21 | Aquanova Ag | Curcuminsolubilisat |
WO2014138426A2 (en) * | 2013-03-07 | 2014-09-12 | Topokine Therapeutics, Inc. | Methods and compositions for reducing body fat and adipocytes |
CN103285401A (zh) * | 2013-05-27 | 2013-09-11 | 沈阳药科大学 | 一种能提高难溶性药物溶解性和生物利用度的组合物 |
US9458086B1 (en) * | 2013-07-03 | 2016-10-04 | University Of South Florida (A Florida Non-Profit Corporation) | Compositions and methods for adipocyte modulation |
WO2015072602A1 (ko) | 2013-11-15 | 2015-05-21 | (주)다미화학 | 난용성 물질의 수용액 가용화 조성물 및 이를 이용한 난용성 물질의 수용액 가용방법 |
US20160287533A1 (en) * | 2013-11-27 | 2016-10-06 | Research Foundation Of The City University Of New York | Activity Enhancing Curcumin Compositions and Methods of Use |
TW201540294A (zh) * | 2014-04-25 | 2015-11-01 | Caliway Biomedical Co Ltd | 用於抑制脂肪細胞、降低體脂肪、減少體重或促進脂肪代謝之植物萃取組成物及其醫藥組合物與用途 |
CN103989659B (zh) * | 2014-05-26 | 2016-09-07 | 重庆医科大学 | 姜黄素纳米结构脂质载体及其制备方法 |
AU2015309351B2 (en) | 2014-08-28 | 2019-01-03 | Caliway Biopharmaceuticals Co., Ltd. | Composition and medicinal product for reducing body weight and body fat, and use of said product |
US10226503B2 (en) | 2014-08-28 | 2019-03-12 | Caliway Biopharmaceuticals Co., Ltd. | Plant extract composition for reducing topical fat and promoting weight loss as well as applications thereof |
JP6473505B2 (ja) * | 2014-08-28 | 2019-02-20 | カリウェイ バイオファーマシューティカルズ カンパニー リミテッド | 局所の脂肪と体重の減少に用いられる組成物およびその医薬品と使用 |
US11318110B2 (en) | 2015-08-28 | 2022-05-03 | Caliway Biopharmaceuticals Co., Ltd. | Pharmaceutical composition for reducing local fat and uses thereof |
MX2018002462A (es) | 2015-08-28 | 2018-06-19 | Caliway Biopharmaceuticals Co Ltd | Una composicion farmaceutica para reducir la grasa localizada y sus usos. |
EP3505168A1 (en) | 2016-08-26 | 2019-07-03 | Caliway Biopharmaceuticals Co., Ltd. | Subcutaneous injection for reducing body weight and application thereof |
-
2016
- 2016-08-26 MX MX2018002462A patent/MX2018002462A/es unknown
- 2016-08-26 CN CN201680046418.3A patent/CN108697668B/zh active Active
- 2016-08-26 KR KR1020207007953A patent/KR102240221B1/ko active IP Right Grant
- 2016-08-26 EP EP16840921.7A patent/EP3381473A4/en active Pending
- 2016-08-26 CA CA2995158A patent/CA2995158C/en active Active
- 2016-08-26 SG SG11201801111RA patent/SG11201801111RA/en unknown
- 2016-08-26 KR KR1020187008137A patent/KR20180037058A/ko active Application Filing
- 2016-08-26 MX MX2018002461A patent/MX2018002461A/es unknown
- 2016-08-26 KR KR1020207012125A patent/KR102356390B1/ko active IP Right Grant
- 2016-08-26 BR BR112018003892-0A patent/BR112018003892A2/pt not_active Application Discontinuation
- 2016-08-26 JP JP2018510970A patent/JP7063803B2/ja active Active
- 2016-08-26 AU AU2016314545A patent/AU2016314545C1/en active Active
- 2016-08-26 TW TW105127452A patent/TWI604859B/zh active
- 2016-08-26 CA CA2995155A patent/CA2995155C/en active Active
- 2016-08-26 BR BR112018003877-6A patent/BR112018003877A2/pt not_active Application Discontinuation
- 2016-08-26 AU AU2016314546A patent/AU2016314546C1/en active Active
- 2016-08-26 IL IL257784A patent/IL257784B2/en unknown
- 2016-08-26 US US15/754,429 patent/US10610496B2/en active Active
- 2016-08-26 TW TW105127451A patent/TWI630922B/zh active
- 2016-08-26 EP EP16840922.5A patent/EP3381451A4/en active Pending
- 2016-08-26 US US15/754,363 patent/US20180243211A1/en active Pending
- 2016-08-26 CN CN202211455288.2A patent/CN115778928A/zh active Pending
- 2016-08-26 KR KR1020187008138A patent/KR102107917B1/ko active IP Right Grant
- 2016-08-26 CN CN201680046431.9A patent/CN109069655A/zh active Pending
- 2016-08-26 WO PCT/IB2016/055101 patent/WO2017037593A2/zh active Application Filing
- 2016-08-26 WO PCT/IB2016/055102 patent/WO2017037594A2/zh active Application Filing
- 2016-08-26 JP JP2018510971A patent/JP7063804B2/ja active Active
-
2017
- 2017-08-24 TW TW106128816A patent/TWI667044B/zh active
- 2017-08-25 JP JP2019510854A patent/JP2019528297A/ja active Pending
- 2017-08-25 RU RU2019108198A patent/RU2753507C2/ru active
-
2018
- 2018-02-27 MX MX2021010359A patent/MX2021010359A/es unknown
- 2018-03-27 CO CONC2018/0003424A patent/CO2018003424A2/es unknown
-
2019
- 2019-10-09 AU AU2019246808A patent/AU2019246808B2/en active Active
- 2019-12-12 AU AU2019280037A patent/AU2019280037B2/en active Active
-
2020
- 2020-01-22 US US16/749,266 patent/US11433034B2/en active Active
- 2020-05-01 JP JP2020081311A patent/JP7054540B2/ja active Active
- 2020-05-01 JP JP2020081316A patent/JP7095903B2/ja active Active
-
2021
- 2021-04-19 AU AU2021202349A patent/AU2021202349B2/en active Active
-
2022
- 2022-07-28 US US17/875,679 patent/US20220362173A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018002462A (es) | Una composicion farmaceutica para reducir la grasa localizada y sus usos. | |
MX2016014320A (es) | Composiciones de suspension de liberacion prolongada. | |
WO2015018380A3 (en) | Therapeutic nanoparticles and the preparation methods thereof | |
MX2020012310A (es) | Formulaciones de liberacion prolongada de colchicina y metodos de uso de las mismas. | |
PH12019502150A1 (en) | Compounds and methods for the treatment of parasitic diseases | |
PH12017502376B1 (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
BR112017009510A2 (pt) | composições compreendendo ciclosporina | |
IN2014MU01042A (es) | ||
MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
MX2017013636A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas. | |
PH12017502149A1 (en) | Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester | |
MD4563C1 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
MX2017009289A (es) | Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas. | |
BR112017019364A2 (pt) | dispersões sólidas | |
MX2017013633A (es) | Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas. | |
PH12016502527B1 (en) | Stabilized desmopressin | |
WO2013168179A3 (en) | Controlled release pharmaceutical formulations of antiviral agents | |
MX2018002449A (es) | Formulaciones de liberacion retardada, metodos de fabricacion y uso de las mismas. | |
WO2016112339A8 (en) | Stable formulations for the oral administration of amphotericin b and related methods | |
GB2541348A (en) | Clopidogrel for use in the treatment of benign prostatic hyperplasia |